Quest Diagnostics Incorporated: insider trading
1,858 trades by 44 directors, officers and 10% owners since 2010, from their SEC Form 4 and 5 filings.
Bought, 12 months
$0
0 purchases by 0 insiders
Sold, 12 months
$47.4 M
41 sales by 9 insiders
Bought, 3 months
$0
0 purchases
Sold, 3 months
$19.8 M
17 sales
Insider buying and selling by month
Open-market purchases and sales by value, last three years.
Insiders (44)
Each insider's latest direct holding and their open-market trades of the last 12 months, most recent first.
| Insider | Shares owned directly | Bought, 12 m | Sold, 12 m | Latest trade |
|---|---|---|---|---|
| Michael J. DeppeSVP, Corp. Controller & CAO | 35,203 | — | $3.1 M | |
| Patrick PlewmanSVP for Diagnostic Services | 14,684 | — | $5.0 M | |
| Catherine T. DohertyExecutive Vice President | 71,949 | — | $12.4 M | |
| Mark E. DelaneySVP & Chief Commercial Officer | 12,975 | — | $376 K | |
| Subu RamachandranSVP, Regional Businesses | 2,832 | — | — | |
| Gary M. PfeifferDirector | 29,802 | — | $292 K | |
| Karthik KuppusamySVP, Clinical Solutions | 13,619 | — | $2.2 M | |
| Robert B. CarterDirector | 3,874 | — | — | |
| Sam SamadExecutive Vice President & CFO | 33,568 | — | — | |
| Timothy L. MainDirector | 22,478 | — | — | |
| Vicky B. GreggDirector | 18,449 | — | $240 K | |
| Wright Lassiter IIIDirector | 10,329 | — | — | |
| J. E. DavisCEO and President, Director | 122,423 | — | $17.1 M | |
| Michael E. PrevoznikSVP & General Counsel | 36,557 | — | $6.6 M | |
| Denise M. MorrisonDirector | 11,929 | — | — | |
| Luis DiazDirector | 5,196 | — | — | |
| Timothy C. WentworthDirector | 1,358 | — | — | |
| Timothy M. RingDirector | 31,140 | — | — | |
| Tracey DoiDirector | 7,748 | — | — | |
| Mark A. GardnerSVP of Molecular Gen & Oncol | 4,673 | — | — | |
| Gail R. WilenskyDirector | 20,506 | — | — | |
| Stephen H. RusckowskiDirector | 389,597 | — | — | |
| Manner Carrie EglintonSVP, Advanced Diagnostics | 48,391 | — | — | |
| Mark GuinanExecutive Vice President & CFO | 98,981 | — | — | |
| Helen TorleyDirector | 6,260 | — | — | |
| Manuel O. MendezSVP & Chief Commercial Officer | 29,045 | — | — | |
| Daniel StanzioneDirector | 28,349 | — | — | |
| Everett CunninghamSVP, Commercial | 38,311 | — | — | |
| Robert A. KlugVP, Corporate Controller | 6,261 | — | — | |
| Jenne K. BritellDirector | 17,660 | — | — | |
| Jeffrey M. LeidenDirector | 6,000 | — | — | |
| Jon R. CohenSVP & Group Exec. Diag. Sol. | 31,757 | — | — | |
| John B. ZieglerDirector | 16,557 | — | — | |
| John C. BaldwinDirector | 12,949 | — | — | |
| Thomas F. BongiornoVP and Corporate Controller | 11,837 | — | — | |
| John B. HaydonSVP, Operations | 19,890 | — | — | |
| William F. BuehlerDirector | 26,225 | — | — | |
| Kathy OrdonezSVP, Diagnostic Solutions | 9,569 | — | — | |
| Robert HagemannSVP & Chief Financial Officer | 126,722 | — | — | |
| Surya N. MohapatraChairman, President & CEO, Director | 243,713 | — | — | |
| Joan Elizabeth MillerSVP-Oncology & Neurology Srvcs | 89,232 | — | — | |
| Wayne R. SimmonsVice President, Operations | 47,150 | — | — | |
| Glaxosmithkline PLCDirector, 10% owner | — | — | — | |
| Rosanne HaggertyDirector | 9,334 | — | — |
Trades#
The newest 300 trades.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Michael J. DeppeSVP, Corp. Controller & CAO | Sell10b5-1 plan | -6,261 | $260.17 | $1.6 M | 35,203 | Form 4 |
| filed | Michael J. DeppeSVP, Corp. Controller & CAO | Sell10b5-1 plan | -5,515 | $260.17 | $1.4 M | 35,203 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Sell10b5-1 plan | -4,274 | $257.34 | $1.1 M | 15,334 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Sell10b5-1 plan | -6,793 | $257.34 | $1.7 M | 15,334 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Sell10b5-1 plan | -650 | $257.34 | $167 K | 14,684 | Form 4 |
| filed | Catherine T. DohertyExecutive Vice President | Sell10b5-1 plan | -3,818 | $245.45 | $937 K | 90,236 | Form 4 |
| filed | Catherine T. DohertyExecutive Vice President | Sell10b5-1 plan | -5,990 | $246.26 | $1.5 M | 84,246 | Form 4 |
| filed | Catherine T. DohertyExecutive Vice President | Sell10b5-1 plan | -1,151 | $246.98 | $284 K | 83,095 | Form 4 |
| filed | Catherine T. DohertyExecutive Vice President | Sell10b5-1 plan | -2,358 | $248.38 | $586 K | 80,737 | Form 4 |
| filed | Catherine T. DohertyExecutive Vice President | Sell10b5-1 plan | -3,004 | $249.40 | $749 K | 77,733 | Form 4 |
| filed | Catherine T. DohertyExecutive Vice President | Sell10b5-1 plan | -2,877 | $250.49 | $721 K | 74,856 | Form 4 |
| filed | Catherine T. DohertyExecutive Vice President | Sell10b5-1 plan | -2,907 | $251.24 | $730 K | 71,949 | Form 4 |
| filed | Gary M. PfeifferDirector | Sell10b5-1 plan | -1,203 | $243.00 | $292 K | 29,802 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -10,000 | $242.72 | $2.4 M | 122,423 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -16,010 | $242.88 | $3.9 M | 44,224 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -6,237 | $243.63 | $1.5 M | 37,987 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -430 | $244.51 | $105 K | 37,557 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Sell10b5-1 plan | -1,600 | $235.18 | $376 K | 10,335 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Sell10b5-1 plan | -8,147 | $200.00 | $1.6 M | 13,510 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -10,000 | $194.14 | $1.9 M | 132,423 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -3,878 | $206.21 | $800 K | 37,557 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Sell10b5-1 plan | -2,855 | $206.21 | $589 K | 15,198 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -5,558 | $206.21 | $1.1 M | 67,122 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Sell | -2,628 | $204.86 | $538 K | 13,441 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -526 | $207.73 | $109 K | 37,557 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Sell10b5-1 plan | -410 | $207.73 | $85 K | 15,198 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -632 | $207.73 | $131 K | 67,122 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -10,000 | $212.52 | $2.1 M | 117,185 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Sell10b5-1 plan | -958 | $204.83 | $196 K | 15,838 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -1,111 | $204.83 | $228 K | 38,371 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -1,433 | $204.83 | $294 K | 68,402 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -10,573 | $205.21 | $2.2 M | 83,660 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -10,122 | $206.37 | $2.1 M | 73,538 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -3,500 | $207.08 | $725 K | 70,038 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -1,619 | $208.21 | $337 K | 68,419 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -351 | $209.10 | $73 K | 68,068 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Sell10b5-1 plan | -5,662 | $204.00 | $1.2 M | 15,381 | Form 4 |
| filed | Vicky B. GreggDirector | Sell | -1,250 | $191.76 | $240 K | 17,037 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -9,342 | $191.59 | $1.8 M | 166,231 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -41,004 | $192.27 | $7.9 M | 125,227 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -4,747 | $192.97 | $916 K | 120,480 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Sell10b5-1 plan | -7,946 | $187.35 | $1.5 M | 7,530 | Form 4 |
| filed | Gary M. PfeifferDirector | Sell | -1,482 | $182.40 | $270 K | 29,431 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -83 | $187.22 | $16 K | 38,261 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -144 | $188.66 | $27 K | 38,117 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -175 | $187.02 | $33 K | 38,117 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -28,288 | $187.12 | $5.3 M | 38,117 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Sell10b5-1 plan | -1,975 | $185.00 | $365 K | 15,269 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Sell10b5-1 plan | -4,532 | $183.00 | $829 K | 17,244 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Sell10b5-1 plan | -1,975 | $180.00 | $356 K | 17,244 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Sell10b5-1 plan | -3,560 | $175.00 | $623 K | 21,185 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Sell10b5-1 plan | -1,975 | $175.00 | $346 K | 19,219 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Sell10b5-1 plan | -2,210 | $170.00 | $376 K | 8,450 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Sell10b5-1 plan | -3,045 | $167.40 | $510 K | 10,660 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Sell10b5-1 plan | -5,224 | $167.40 | $874 K | 10,660 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Sell10b5-1 plan | -874 | $175.31 | $153 K | 7,498 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Sell10b5-1 plan | -874 | $175.72 | $154 K | 8,372 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Sell10b5-1 plan | -2,555 | $170.00 | $434 K | 10,575 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -2,366 | $168.03 | $398 K | 164,448 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -1,411 | $168.76 | $238 K | 163,037 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -704 | $169.63 | $119 K | 162,333 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -7,249 | $167.86 | $1.2 M | 155,084 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -4,905 | $168.72 | $828 K | 150,179 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -2,764 | $169.56 | $469 K | 147,415 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -6,950 | $167.86 | $1.2 M | 140,465 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -5,900 | $168.66 | $995 K | 134,565 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -2,493 | $169.57 | $423 K | 132,072 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -750 | $167.86 | $126 K | 131,322 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -584 | $168.70 | $99 K | 130,738 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -267 | $169.60 | $45 K | 130,471 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -1,493 | $167.88 | $251 K | 128,978 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -902 | $168.79 | $152 K | 128,076 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -453 | $169.63 | $77 K | 127,623 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -4,643 | $170.00 | $789 K | 38,117 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -5,370 | $174.13 | $935 K | 68,068 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -716 | $175.79 | $126 K | 68,068 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -592 | $175.79 | $104 K | 38,117 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -824 | $172.61 | $142 K | 69,178 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -528 | $172.61 | $91 K | 39,031 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -899 | $170.99 | $154 K | 70,457 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -604 | $170.99 | $103 K | 39,845 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Sell | -320 | $169.71 | $54 K | 18,082 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -535 | $169.71 | $91 K | 71,356 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Sell | -403 | $164.30 | $66 K | 4,624 | Form 4 |
| filed | Vicky B. GreggDirector | Sell | -1,250 | $164.57 | $206 K | 16,867 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -3,009 | $162.26 | $488 K | 70,615 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -32,137 | $163.15 | $5.2 M | 38,478 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -4,803 | $162.14 | $779 K | 96,712 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -28,300 | $163.13 | $4.6 M | 68,412 | Form 4 |
| filed | Michael J. DeppeSVP, Corp. Controller & CAO | Sell10b5-1 plan | -2,100 | $152.70 | $321 K | 51,596 | Form 4 |
| filed | Michael J. DeppeSVP, Corp. Controller & CAO | Sell10b5-1 plan | -2,400 | $153.98 | $370 K | 49,196 | Form 4 |
| filed | Michael J. DeppeSVP, Corp. Controller & CAO | Sell10b5-1 plan | -4,135 | $154.74 | $640 K | 45,061 | Form 4 |
| filed | Michael J. DeppeSVP, Corp. Controller & CAO | Sell10b5-1 plan | -2,600 | $152.71 | $397 K | 42,461 | Form 4 |
| filed | Michael J. DeppeSVP, Corp. Controller & CAO | Sell10b5-1 plan | -2,331 | $154.03 | $359 K | 40,130 | Form 4 |
| filed | Michael J. DeppeSVP, Corp. Controller & CAO | Sell10b5-1 plan | -5,189 | $154.74 | $803 K | 34,941 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Sell | -1,775 | $156.92 | $279 K | 9,734 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell | -32,551 | $154.97 | $5.0 M | 38,478 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Sell | -1,990 | $153.26 | $305 K | 11,459 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Sell | -420 | $143.08 | $60 K | 5,019 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Sell10b5-1 plan | -1,760 | $140.00 | $246 K | 13,435 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -5,611 | $125.88 | $706 K | 38,478 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -1,187 | $125.88 | $149 K | 68,412 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -5,557 | $126.57 | $703 K | 69,599 | Form 4 |
| filed | Vicky B. GreggDirector | Sell | -2,500 | $126.64 | $317 K | 16,329 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -661 | $126.14 | $83 K | 40,206 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -821 | $126.14 | $104 K | 70,800 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -4,754 | $140.55 | $668 K | 38,527 | Form 4 |
| filed | Catherine T. DohertySVP, Regional Businesses | Sell10b5-1 plan | -5,307 | $140.55 | $746 K | 67,810 | Form 4 |
| filed | Catherine T. DohertySVP, Regional Businesses | Sell10b5-1 plan | -717 | $140.63 | $101 K | 67,810 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -593 | $138.54 | $82 K | 38,527 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -1,415 | $141.42 | $200 K | 39,440 | Form 4 |
| filed | Catherine T. DohertySVP, Regional Businesses | Sell10b5-1 plan | -1,690 | $141.42 | $239 K | 68,919 | Form 4 |
| filed | Timothy M. RingDirector | Sell10b5-1 plan | -2,025 | $152.50 | $309 K | 24,149 | Form 4 |
| filed | Catherine T. DohertySVP, Regional Businesses | Sell10b5-1 plan | -17,358 | $148.92 | $2.6 M | 91,140 | Form 4 |
| filed | Catherine T. DohertySVP, Regional Businesses | Sell10b5-1 plan | -23,407 | $149.37 | $3.5 M | 67,733 | Form 4 |
| filed | Timothy M. RingDirector | Sell | -2,000 | $144.06 | $288 K | 24,149 | Form 4 |
| filed | Michael J. DeppeVP, Corp. Controller & CAO | Sell10b5-1 plan | -15,497 | $145.00 | $2.2 M | 32,013 | Form 4 |
| filed | Timothy M. RingDirector | Sell10b5-1 plan | -2,000 | $123.39 | $247 K | 23,933 | Form 4 |
| filed | Timothy M. RingDirector | Sell10b5-1 plan | -2,000 | $125.02 | $250 K | 23,933 | Form 4 |
| filed | Timothy M. RingDirector | Sell10b5-1 plan | -2,000 | $136.04 | $272 K | 23,933 | Form 4 |
| filed | Timothy M. RingDirector | Sell10b5-1 plan | -2,000 | $133.47 | $267 K | 23,933 | Form 4 |
| filed | Stephen H. RusckowskiChairman, CEO and President, Director | Sell10b5-1 plan | -6,821 | $140.60 | $959 K | 338,049 | Form 4 |
| filed | Stephen H. RusckowskiChairman, CEO and President, Director | Sell10b5-1 plan | -2,565 | $141.36 | $363 K | 335,484 | Form 4 |
| filed | Stephen H. RusckowskiChairman, CEO and President, Director | Sell10b5-1 plan | -651 | $142.15 | $93 K | 334,833 | Form 4 |
| filed | Stephen H. RusckowskiChairman, CEO and President, Director | Sell10b5-1 plan | -9,823 | $140.58 | $1.4 M | 339,864 | Form 4 |
| filed | Stephen H. RusckowskiChairman, CEO and President, Director | Sell10b5-1 plan | -4,131 | $141.35 | $584 K | 335,733 | Form 4 |
| filed | Stephen H. RusckowskiChairman, CEO and President, Director | Sell10b5-1 plan | -900 | $142.13 | $128 K | 334,833 | Form 4 |
| filed | Stephen H. RusckowskiChairman, CEO and President, Director | Sell10b5-1 plan | -126,126 | $140.12 | $17.7 M | 334,833 | Form 4 |
| filed | Stephen H. RusckowskiChairman, CEO and President, Director | Sell | -156,282 | $140.12 | $21.9 M | 334,833 | Form 4 |
| filed | Stephen H. RusckowskiChairman, CEO and President, Director | Sell10b5-1 plan | -33,898 | $140.12 | $4.7 M | 335,833 | Form 4 |
| filed | Stephen H. RusckowskiChairman, CEO and President, Director | Sell10b5-1 plan | -800 | $141.54 | $113 K | 335,033 | Form 4 |
| filed | Stephen H. RusckowskiChairman, CEO and President, Director | Sell10b5-1 plan | -200 | $142.26 | $28 K | 334,833 | Form 4 |
| filed | Stephen H. RusckowskiChairman, CEO and President, Director | Sell10b5-1 plan | -41,268 | $140.12 | $5.8 M | 336,133 | Form 4 |
| filed | Stephen H. RusckowskiChairman, CEO and President, Director | Sell10b5-1 plan | -1,000 | $141.51 | $142 K | 335,133 | Form 4 |
| filed | Stephen H. RusckowskiChairman, CEO and President, Director | Sell10b5-1 plan | -300 | $142.24 | $43 K | 334,833 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell | -50,604 | $139.97 | $7.1 M | 39,224 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -6,228 | $135.21 | $842 K | 39,224 | Form 4 |
| filed | Catherine T. DohertySVP, Group Exec. Clin. Fran. | Sell10b5-1 plan | -7,032 | $135.21 | $951 K | 67,733 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell | -661 | $130.00 | $86 K | 39,224 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -1,669 | $126.26 | $211 K | 37,144 | Form 4 |
| filed | Catherine T. DohertySVP, Group Exec. Clin. Fran. | Sell10b5-1 plan | -2,750 | $126.26 | $347 K | 64,405 | Form 4 |
| filed | Catherine T. DohertySVP, Group Exec. Clin. Fran. | Sell10b5-1 plan | -300 | $153.38 | $46 K | 105,994 | Form 4 |
| filed | Catherine T. DohertySVP, Group Exec. Clin. Fran. | Sell10b5-1 plan | -3,250 | $154.79 | $503 K | 102,744 | Form 4 |
| filed | Catherine T. DohertySVP, Group Exec. Clin. Fran. | Sell10b5-1 plan | -3,532 | $155.77 | $550 K | 99,212 | Form 4 |
| filed | Catherine T. DohertySVP, Group Exec. Clin. Fran. | Sell10b5-1 plan | -15,908 | $156.86 | $2.5 M | 83,304 | Form 4 |
| filed | Catherine T. DohertySVP, Group Exec. Clin. Fran. | Sell10b5-1 plan | -14,575 | $157.53 | $2.3 M | 68,729 | Form 4 |
| filed | Stephen H. RusckowskiChairman, CEO and President, Director | Sell10b5-1 plan | -5,300 | $140.59 | $745 K | 284,427 | Form 4 |
| filed | Stephen H. RusckowskiChairman, CEO and President, Director | Sell10b5-1 plan | -4,193 | $141.22 | $592 K | 284,427 | Form 4 |
| filed | Stephen H. RusckowskiChairman, CEO and President, Director | Sell10b5-1 plan | -139,751 | $140.14 | $19.6 M | 284,427 | Form 4 |
| filed | Gail R. WilenskyDirector | Sell | -6,111 | $139.32 | $851 K | 17,845 | Form 4 |
| filed | Gail R. WilenskyDirector | Sell | -6,111 | $139.27 | $851 K | 17,845 | Form 4 |
| filed | Stephen H. RusckowskiChairman, CEO and President, Director | Sell10b5-1 plan | -32,788 | $140.01 | $4.6 M | 284,427 | Form 4 |
| filed | Stephen H. RusckowskiChairman, CEO and President, Director | Sell10b5-1 plan | -5,813 | $140.03 | $814 K | 284,427 | Form 4 |
| filed | Catherine T. DohertySVP, Group Exec. Clin. Fran. | Sell | -8,536 | $139.96 | $1.2 M | 68,729 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -44,939 | $137.00 | $6.2 M | 40,152 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -5,574 | $120.47 | $671 K | 40,152 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -801 | $115.49 | $93 K | 40,152 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -438 | $116.95 | $51 K | 41,703 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -750 | $116.95 | $88 K | 40,953 | Form 4 |
| filed | Mark GuinanExecutive Vice President & CFO | Sell10b5-1 plan | -59,193 | $120.06 | $7.1 M | 96,142 | Form 4 |
| filed | Mark GuinanExecutive Vice President & CFO | Sell10b5-1 plan | -22,563 | $121.18 | $2.7 M | 73,579 | Form 4 |
| filed | Gail R. WilenskyDirector | Sell | -6,111 | $126.02 | $770 K | 16,482 | Form 4 |
| filed | Daniel StanzioneDirector | Sell10b5-1 plan | -5,621 | $125.73 | $707 K | 33,951 | Form 4 |
| filed | Daniel StanzioneDirector | Sell10b5-1 plan | -3,302 | $126.46 | $418 K | 30,649 | Form 4 |
| filed | Daniel StanzioneDirector | Sell10b5-1 plan | -2,300 | $127.45 | $293 K | 28,349 | Form 4 |
| filed | Michael J. DeppeVP, Corp. Controller & CAO | Sell | -5,700 | $125.00 | $713 K | 29,785 | Form 4 |
| filed | Michael J. DeppeVP, Corp. Controller & CAO | Sell | -4,750 | $125.00 | $594 K | 25,090 | Form 4 |
| filed | Stephen H. RusckowskiChairman, CEO and President, Director | Sell10b5-1 plan | -291,997 | $120.00 | $35.0 M | 237,747 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell | -35,591 | $119.00 | $4.2 M | 40,087 | Form 4 |
| filed | Catherine T. DohertySVP, Group Exec. Clin. Fran. | Sell10b5-1 plan | -54,616 | $110.57 | $6.0 M | 72,187 | Form 4 |
| filed | Catherine T. DohertySVP, Group Exec. Clin. Fran. | Sell10b5-1 plan | -3,776 | $111.13 | $420 K | 68,411 | Form 4 |
| filed | Mark GuinanExecutive Vice President & CFO | Sell10b5-1 plan | -45,826 | $116.81 | $5.4 M | 100,349 | Form 4 |
| filed | Mark GuinanExecutive Vice President & CFO | Sell10b5-1 plan | -18,246 | $117.65 | $2.1 M | 82,103 | Form 4 |
| filed | Mark GuinanExecutive Vice President & CFO | Sell10b5-1 plan | -8,524 | $118.60 | $1.0 M | 73,579 | Form 4 |
| filed | Timothy M. RingDirector | Sell10b5-1 plan | -11,730 | $116.60 | $1.4 M | 20,505 | Form 4 |
| filed | Manner Carrie EglintonSVP, Advanced Diagnostics | Sell10b5-1 plan | -2,500 | $112.03 | $280 K | 24,890 | Form 4 |
| filed | Stephen H. RusckowskiChairman, CEO and President, Director | Sell10b5-1 plan | -11,717 | $112.01 | $1.3 M | 237,747 | Form 4 |
| filed | Manner Carrie EglintonSVP, Advanced Diagnostics | Sell10b5-1 plan | -2,500 | $110.00 | $275 K | 22,390 | Form 4 |
| filed | J. E. DavisEVP, General Diagnostics | Sell10b5-1 plan | -200 | $85.59 | $17 K | 41,399 | Form 4 |
| filed | J. E. DavisEVP, General Diagnostics | Sell10b5-1 plan | -1,085 | $86.65 | $94 K | 40,314 | Form 4 |
| filed | J. E. DavisEVP, General Diagnostics | Sell10b5-1 plan | -1,307 | $87.81 | $115 K | 39,007 | Form 4 |
| filed | J. E. DavisEVP, General Diagnostics | Sell10b5-1 plan | -421 | $88.53 | $37 K | 38,586 | Form 4 |
| filed | J. E. DavisEVP, General Diagnostics | Sell10b5-1 plan | -500 | $90.15 | $45 K | 38,086 | Form 4 |
| filed | Catherine T. DohertySVP, Group Exec. Clin. Fran. | Sell10b5-1 plan | -2,501 | $104.25 | $261 K | 68,411 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -2,175 | $104.25 | $227 K | 40,087 | Form 4 |
| filed | Stephen H. RusckowskiChairman, CEO and President, Director | Sell10b5-1 plan | -100 | $112.19 | $11 K | 237,747 | Form 4 |
| filed | Stephen H. RusckowskiChairman, CEO and President, Director | Sell10b5-1 plan | -171,025 | $112.21 | $19.2 M | 285,713 | Form 4 |
| filed | Stephen H. RusckowskiChairman, CEO and President, Director | Sell10b5-1 plan | -36,790 | $113.65 | $4.2 M | 248,923 | Form 4 |
| filed | Stephen H. RusckowskiChairman, CEO and President, Director | Sell10b5-1 plan | -16,426 | $114.24 | $1.9 M | 232,497 | Form 4 |
| filed | Stephen H. RusckowskiChairman, CEO and President, Director | Sell10b5-1 plan | -3,937 | $115.45 | $455 K | 228,560 | Form 4 |
| filed | Stephen H. RusckowskiChairman, CEO and President, Director | Sell10b5-1 plan | -2,000 | $116.27 | $233 K | 226,560 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -690 | $109.02 | $75 K | 40,087 | Form 4 |
| filed | Catherine T. DohertySVP, Group Exec. Clin. Fran. | Sell10b5-1 plan | -789 | $109.02 | $86 K | 68,411 | Form 4 |
| filed | J. E. DavisEVP, General Diagnostics | Sell10b5-1 plan | -1,100 | $109.02 | $120 K | 38,105 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -321 | $111.09 | $36 K | 41,445 | Form 4 |
| filed | Catherine T. DohertySVP, Group Exec. Clin. Fran. | Sell10b5-1 plan | -368 | $111.09 | $41 K | 69,977 | Form 4 |
| filed | J. E. DavisEVP, General Diagnostics | Sell10b5-1 plan | -510 | $111.09 | $57 K | 40,392 | Form 4 |
| filed | J. E. DavisEVP, General Diagnostics | Sell10b5-1 plan | -598 | $112.73 | $67 K | 41,454 | Form 4 |
| filed | Catherine T. DohertySVP, Group Exec. Clin. Fran. | Sell10b5-1 plan | -405 | $112.73 | $46 K | 70,701 | Form 4 |
| filed | J. E. DavisEVP, General Diagnostics | Sell10b5-1 plan | -58,258 | $105.46 | $6.1 M | 121,822 | Form 4 |
| filed | J. E. DavisEVP, General Diagnostics | Sell10b5-1 plan | -7,423 | $106.51 | $791 K | 114,399 | Form 4 |
| filed | J. E. DavisEVP, General Diagnostics | Sell10b5-1 plan | -69,003 | $105.45 | $7.3 M | 45,396 | Form 4 |
| filed | J. E. DavisEVP, General Diagnostics | Sell10b5-1 plan | -8,853 | $106.51 | $943 K | 36,543 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell | -11,863 | $107.15 | $1.3 M | 72,151 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell | -32,193 | $107.53 | $3.5 M | 39,958 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell | -500 | $107.83 | $54 K | 39,458 | Form 4 |
| filed | Gail R. WilenskyDirector | Sell | -8,000 | $107.17 | $857 K | 14,951 | Form 4 |
| filed | Michael J. DeppeVP, Corp. Controller & CAO | Sell10b5-1 plan | -5,000 | $106.00 | $530 K | 23,732 | Form 4 |
| filed | Mark GuinanExecutive Vice President & CFO | Sell | -73,005 | $100.00 | $7.3 M | 66,017 | Form 4 |
| filed | Stephen H. RusckowskiChairman, President and CEO, Director | Sell | -244,565 | $100.00 | $24.5 M | 213,049 | Form 4 |
| filed | J. E. DavisEVP, General Diagnostics | Sell10b5-1 plan | -47,574 | $95.00 | $4.5 M | 36,534 | Form 4 |
| filed | J. E. DavisEVP, General Diagnostics | Sell10b5-1 plan | -5,900 | $90.15 | $532 K | 38,634 | Form 4 |
| filed | J. E. DavisEVP, General Diagnostics | Sell10b5-1 plan | -2,100 | $90.70 | $190 K | 36,534 | Form 4 |
| filed | Catherine T. DohertySVP, Group Exec. Clin. Fran. | Sell10b5-1 plan | -60,492 | $90.59 | $5.5 M | 73,416 | Form 4 |
| filed | Catherine T. DohertySVP, Group Exec. Clin. Fran. | Sell10b5-1 plan | -5,890 | $90.59 | $534 K | 67,526 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -3,373 | $86.81 | $293 K | 39,458 | Form 4 |
| filed | Everett CunninghamSVP, Commercial | Sell10b5-1 plan | -3,892 | $86.81 | $338 K | 38,311 | Form 4 |
| filed | Everett CunninghamSVP, Commercial | Sell10b5-1 plan | -1,144 | $86.51 | $99 K | 38,259 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -1,048 | $86.51 | $91 K | 39,453 | Form 4 |
| filed | Everett CunninghamSVP, Commercial | Sell10b5-1 plan | -352 | $87.06 | $31 K | 39,403 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -364 | $87.06 | $32 K | 40,501 | Form 4 |
| filed | Everett CunninghamSVP, Commercial | Sell10b5-1 plan | -326 | $88.23 | $29 K | 40,867 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -336 | $88.23 | $30 K | 41,772 | Form 4 |
| filed | Gail R. WilenskyDirector | Sell | -8,000 | $87.78 | $702 K | 26,604 | Form 4 |
| filed | Everett CunninghamSVP, Commercial | Sell10b5-1 plan | -40,328 | $112.00 | $4.5 M | 38,261 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -30,780 | $113.07 | $3.5 M | 39,791 | Form 4 |
| filed | Everett CunninghamSVP, Commercial | Sell10b5-1 plan | -19,798 | $109.64 | $2.2 M | 47,412 | Form 4 |
| filed | Everett CunninghamSVP, Commercial | Sell10b5-1 plan | -1,496 | $110.12 | $165 K | 45,916 | Form 4 |
| filed | Everett CunninghamSVP, Commercial | Sell10b5-1 plan | -33,345 | $109.60 | $3.7 M | 51,499 | Form 4 |
| filed | Everett CunninghamSVP, Commercial | Sell10b5-1 plan | -5,583 | $110.07 | $615 K | 45,916 | Form 4 |
| filed | Everett CunninghamSVP, Commercial | Sell10b5-1 plan | -7,066 | $109.63 | $775 K | 38,850 | Form 4 |
| filed | Everett CunninghamSVP, Commercial | Sell10b5-1 plan | -781 | $110.12 | $86 K | 38,261 | Form 4 |
| filed | Jeffrey M. LeidenDirector | Sell | -1,644 | $105.61 | $174 K | 6,000 | Form 4 |
| filed | Mark GuinanExecutive Vice President & CFO | Sell10b5-1 plan | -36,573 | $105.42 | $3.9 M | 83,160 | Form 4 |
| filed | Stephen H. RusckowskiChairman, President and CEO, Director | Sell10b5-1 plan | -168,490 | $107.00 | $18.0 M | 191,069 | Form 4 |
| filed | Mark GuinanExecutive Vice President & CFO | Sell10b5-1 plan | -24,960 | $106.14 | $2.6 M | 58,200 | Form 4 |
| filed | Jon R. CohenSVP & Group Exec. Diag. Sol. | Sell10b5-1 plan | -18,037 | $104.09 | $1.9 M | 97,389 | Form 4 |
| filed | Jon R. CohenSVP & Group Exec. Diag. Sol. | Sell10b5-1 plan | -1,427 | $104.76 | $149 K | 95,962 | Form 4 |
| filed | Jon R. CohenSVP & Group Exec. Diag. Sol. | Sell10b5-1 plan | -18,164 | $104.09 | $1.9 M | 77,798 | Form 4 |
| filed | Jon R. CohenSVP & Group Exec. Diag. Sol. | Sell10b5-1 plan | -1,300 | $104.77 | $136 K | 76,498 | Form 4 |
| filed | Jon R. CohenSVP & Group Exec. Diag. Sol. | Sell10b5-1 plan | -34,168 | $104.09 | $3.6 M | 42,330 | Form 4 |
| filed | Jon R. CohenSVP & Group Exec. Diag. Sol. | Sell10b5-1 plan | -2,800 | $104.77 | $293 K | 39,530 | Form 4 |
| filed | Jon R. CohenSVP & Group Exec. Diag. Sol. | Sell10b5-1 plan | -7,773 | $104.77 | $814 K | 31,757 | Form 4 |
| filed | Catherine T. DohertySVP, Group Exec. Clin. Fran. | Sell10b5-1 plan | -5,556 | $101.00 | $561 K | 67,941 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -4,128 | $101.00 | $417 K | 39,771 | Form 4 |
| filed | J. E. DavisEVP, General Diagnostics | Sell10b5-1 plan | -5,122 | $101.00 | $517 K | 37,067 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -496 | $104.99 | $52 K | 39,766 | Form 4 |
| filed | Catherine T. DohertySVP, Group Exec. Clin. Fran. | Sell10b5-1 plan | -572 | $104.99 | $60 K | 67,941 | Form 4 |
| filed | J. E. DavisEVP, General Diagnostics | Sell10b5-1 plan | -648 | $104.99 | $68 K | 37,023 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -927 | $104.10 | $97 K | 40,262 | Form 4 |
| filed | Catherine T. DohertySVP, Group Exec. Clin. Fran. | Sell10b5-1 plan | -1,248 | $104.10 | $130 K | 68,513 | Form 4 |
| filed | J. E. DavisEVP, General Diagnostics | Sell10b5-1 plan | -1,150 | $104.10 | $120 K | 37,671 | Form 4 |
| filed | Robert A. KlugVP, Corporate Controller | Sell | -1,157 | $103.66 | $120 K | 3,903 | Form 4 |
| filed | J. E. DavisEVP, General Diagnostics | Sell10b5-1 plan | -494 | $102.74 | $51 K | 39,677 | Form 4 |
| filed | Catherine T. DohertySVP, Group Exec. Clin. Fran. | Sell10b5-1 plan | -397 | $102.74 | $41 K | 70,317 | Form 4 |
| filed | Stephen H. RusckowskiChairman, President and CEO, Director | Sell10b5-1 plan | -106,840 | $107.00 | $11.4 M | 166,116 | Form 4 |
| filed | Catherine T. DohertySVP, Group Exec. Clin. Fran. | Sell10b5-1 plan | -21,294 | $104.00 | $2.2 M | 69,415 | Form 4 |
| filed | J. E. DavisEVP, General Diagnostics | Sell10b5-1 plan | -63,880 | $98.68 | $6.3 M | 38,053 | Form 4 |
| filed | Stephen H. RusckowskiChairman, President and CEO, Director | Sell10b5-1 plan | -5,302 | $108.12 | $573 K | 166,116 | Form 4 |
| filed | Stephen H. RusckowskiChairman, President and CEO, Director | Sell10b5-1 plan | -53,933 | $108.16 | $5.8 M | 166,116 | Form 4 |
| filed | Daniel StanzioneDirector | Sell | -40,900 | $108.07 | $4.4 M | 34,675 | Form 4 |
| filed | Stephen H. RusckowskiChairman, President and CEO, Director | Sell10b5-1 plan | -2,525 | $108.03 | $273 K | 166,116 | Form 4 |
| filed | Daniel StanzioneDirector | Sell10b5-1 plan | -3,803 | $108.01 | $411 K | 34,675 | Form 4 |
| filed | Jeffrey M. LeidenDirector | Sell | -296 | $106.66 | $32 K | 6,000 | Form 4 |
| filed | Jeffrey M. LeidenDirector | Sell | -1,304 | $108.73 | $142 K | 6,296 | Form 4 |
| filed | Catherine T. DohertySVP, Group Exec. Clin. Fran. | Sell10b5-1 plan | -8,852 | $107.54 | $952 K | 120,325 | Form 4 |
| filed | Jon R. CohenSVP & Group Exec. Diag. Sol. | Sell10b5-1 plan | -13,344 | $107.52 | $1.4 M | 166,739 | Form 4 |
| filed | Jon R. CohenSVP & Group Exec. Diag. Sol. | Sell10b5-1 plan | -336 | $108.15 | $36 K | 166,403 | Form 4 |
| filed | Catherine T. DohertySVP, Group Exec. Clin. Fran. | Sell10b5-1 plan | -315 | $108.16 | $34 K | 120,010 | Form 4 |
| filed | Jon R. CohenSVP & Group Exec. Diag. Sol. | Sell10b5-1 plan | -28,182 | $107.53 | $3.0 M | 138,221 | Form 4 |
| filed | Catherine T. DohertySVP, Group Exec. Clin. Fran. | Sell10b5-1 plan | -42,636 | $107.52 | $4.6 M | 77,374 | Form 4 |
| filed | Jon R. CohenSVP & Group Exec. Diag. Sol. | Sell10b5-1 plan | -1,158 | $108.14 | $125 K | 137,063 | Form 4 |
| filed | Catherine T. DohertySVP, Group Exec. Clin. Fran. | Sell10b5-1 plan | -1,364 | $108.14 | $148 K | 76,010 | Form 4 |
| filed | Jon R. CohenSVP & Group Exec. Diag. Sol. | Sell10b5-1 plan | -61,321 | $107.53 | $6.6 M | 75,742 | Form 4 |
| filed | Catherine T. DohertySVP, Group Exec. Clin. Fran. | Sell10b5-1 plan | -6,418 | $107.54 | $690 K | 69,592 | Form 4 |
| filed | Catherine T. DohertySVP, Group Exec. Clin. Fran. | Sell10b5-1 plan | -177 | $108.15 | $19 K | 69,415 | Form 4 |
| filed | Jon R. CohenSVP & Group Exec. Diag. Sol. | Sell10b5-1 plan | -2,559 | $108.13 | $277 K | 73,183 | Form 4 |
| filed | Jenne K. BritellDirector | Sellindirect | -6,111 | $104.03 | $636 K | 19,903 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -1,013 | $100.00 | $101 K | 40,322 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -28,500 | $100.00 | $2.9 M | 40,327 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -13,987 | $100.00 | $1.4 M | 40,322 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -4,478 | $98.29 | $440 K | 40,322 | Form 4 |
| filed | Catherine T. DohertySVP, Group Exec. Clin. Fran. | Sell10b5-1 plan | -6,028 | $98.29 | $592 K | 74,155 | Form 4 |
| filed | Catherine T. DohertySVP, Group Exec. Clin. Fran. | Sell10b5-1 plan | -1,134 | $98.25 | $111 K | 80,183 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -470 | $97.77 | $46 K | 40,317 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -440 | $97.39 | $43 K | 41,294 | Form 4 |
| filed | John B. ZieglerDirector | Sell | -2,000 | $95.51 | $191 K | 16,557 | Form 4 |
| filed | Catherine T. DohertySVP, Clin. Franchise Solutions | Sell | -1,615 | $94.65 | $153 K | 73,380 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -1,200 | $93.76 | $113 K | 39,493 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell | -30,000 | $92.40 | $2.8 M | 41,918 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell | -15,000 | $92.38 | $1.4 M | 41,986 | Form 4 |
| filed | Catherine T. DohertySVP, Clin. Franchise Solutions | Sell | -31,100 | $90.42 | $2.8 M | 88,221 | Form 4 |
| filed | Catherine T. DohertySVP, Clin. Franchise Solutions | Sell | -11,486 | $91.61 | $1.1 M | 76,735 | Form 4 |
| filed | Catherine T. DohertySVP, Clin. Franchise Solutions | Sell | -37,414 | $90.40 | $3.4 M | 76,735 | Form 4 |
| filed | Gary M. PfeifferDirector | Sell | -8,000 | $85.01 | $680 K | 22,008 | Form 4 |
| filed | Gary M. PfeifferDirector | Sell | -8,000 | $84.94 | $680 K | 22,008 | Form 4 |
| filed | Gary M. PfeifferDirector | Sell | -6,111 | $85.07 | $520 K | 22,008 | Form 4 |
| filed | Gary M. PfeifferDirector | Sell | -6,111 | $85.09 | $520 K | 22,008 | Form 4 |
| filed | Gary M. PfeifferDirector | Sell | -6,111 | $85.18 | $521 K | 22,008 | Form 4 |
| filed | Gary M. PfeifferDirector | Sell | -8,310 | $85.25 | $708 K | 13,698 | Form 4 |